Precocious puberty
|
|
|
Central precocious puberty |
Monogenic causes: |
|
(1) Gain-of-function (activating) mutations in KISS1R and KISS1 genes (kisspeptin pathway genes) |
|
(2) Loss-of-function (inactivating) mutations in MKRN3 gene |
|
(3) Loss-of-function (inactivating) mutations in DLK1 gene |
|
Chromosomal abnormalities: |
|
(1) 1p36 deletion |
|
(2) 9p distal deletion |
|
(3) 9q34.3 duplication (which includes the NOTCH gene) |
|
(4) Xp11.23-p11.22 duplication |
|
Peripheral precocious puberty |
(1) Testotoxicosis: constitutive activation germline mutations in the LHCGR gene |
|
(2) McCune Albright syndrome: postzygous somatic activating mutations in GNAS
|
|
Genetics of delayed puberty
|
|
|
Constitutional delay of growth and puberty |
Genetic background is unknown. Probably pathogenic variants in the IGSF10 gene have been associated |
|
Kallmann syndrome |
Mutated genes: KAL1, FGFR1, FGF8, FGF17, IL17RD, DUSP6, SPRY4, FLRT3, KLB, HS6ST1, CHD7, WDR11, SEMA3A, SEMA3E, IGSF10, SMCHD1, CCDC141, FEZF1, SOX10, PROKR2, PROK2
|
|
|
|
Normosmic idiopathic hypogonadotropic hypogonadism |
Mutated genes: CHD7, DAX1, FGF8, FGF17, FGFR1, HS6ST1, NSMF, LEP, LEPR, PROK2, PROKR2, WDR11, GNRH1, GNRHR, KISS1, KISS1R, SRA1, TAC3, TACR3
|
|
Hypogonadism hypergonadotropic |
Monogenic causes: |
|
(1) Enzymatic defects in testosterone biosynthesis: 17α-hydroxylase, 3β-hydroxysteroid dehydrogenase, |
|
17, 20-lyase and 17β-hydroxysteroid dehydrogenase deficiency |
|
(2) Inactivating mutations in the gonadotropin receptor genes |
|
(3) Polymalformative syndromes |
|
Chromosomal abnormalities: |
|
(1) Turner syndrome |
|
(2) Klinefelter syndrome |